...
首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >Prevalence of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis
【24h】

Prevalence of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis

机译:伊朗2型糖尿病患者心血管疾病的患病率:系统审查与荟萃分析

获取原文
           

摘要

Background. Type 2 diabetes mellitus (DM) is the most common type of DM and accounts for 90% of the cases. One of the most important complications of type 2 DM is cardiovascular complications, which are the most common cause of mortality in patients with DM. Various studies have reported different incidence rates of cardiovascular disease in patients with type 2 DM. However, no comprehensive review of previous studies has been done. This study is aimed at determining the prevalence of cardiovascular disease in patients with type 2 diabetes mellitus in Iran with a systematic review and meta-analysis. Methods. In this review, studies were first extracted searching domestic and international databases including SID, MagIran, IranMedex, IranDoc, Cochrane, Embase, ScienceDirect, Scopus, PubMed, and Web of Science (ISI), published between 2001 and September 2019. The random effects model was adopted for the analysis, and heterogeneity of the extracted studies was investigated with the index. The data collected from the extracted studies were analyzed using a comprehensive meta-analysis (Version 2) software. Results. The prevalence of cardiovascular disease in patients with type 2 DM in Iran in 17 studies with a sample size of 9656 was 37.4% (95% CI: 31.4-43.8). Based on meta-regression, there was a significant difference on the effect of year of conducting the study and sample size with the prevalence of cardiovascular disease in patients with type 2 DM in Iran (). Conclusion. The results of this study indicated that there was a high prevalence rate of cardiovascular disease in patients with type 2 DM in Iran. Therefore, appropriate strategies should be taken to improve this situation and trace and supervise it at all levels, providing feedback to hospitals.
机译:背景。 2型糖尿病(DM)是最常见的DM类型,占90%的病例。 2型DM最重要的并发症之一是心血管并发症,这是DM患者患者死亡率最常见的原因。各种研究报告了2 DM患者的心血管疾病发病率不同。但是,没有完成以前研究的全面审查。本研究旨在确定伊朗2型糖尿病患者心血管疾病的患病率,具有系统审查和荟萃分析。方法。在本次审查中,首先提取研究在2001年至2019年至9月期间,在包括SID,Magiran,Iranmedex,Irandoc,Cochrane,Emalase,ScieCence,Scopus,Pubmed和SciEdirect,Scopus,PubMed和ScieCentirect,Scopus,Pubmed和Web(Isi)之间进行了研究。随机效应采用模型进行分析,并用指数研究提取的研究的异质性。使用全面的Meta-Analysis(版本2)软件分析从提取的研究中收集的数据。结果。 17项研究中伊朗患者患者的心血管疾病患病率为9656的样本量为37.4%(95%CI:31.4-43.8)。基于Meta回归,对伊朗型2 dM患者的心血管疾病患病率进行研究和样本量的效果显着差异。结论。该研究的结果表明,伊朗2 dm患者患有高患病率的心血管疾病患病率高。因此,应采取适当的策略来改善这种情况和追踪,并在各级监督,为医院提供反馈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号